1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA). NIMHD, through the NIH SBIR/STTR program, allocates grant funding for small businesses working with communities experiencing health and/or healthcare disparities.
Get alerted about grants like this
Save a search for “National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Expired NOT-OD-25-076: Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) This notice has expired. Check the NIH Guide for active opportunities and notices.
Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) July 03, 2024 - PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required). See NOFO PA-24-246 .
NATIONAL INSTITUTES OF HEALTH ( NIH ) The purpose of this notice is to extend the expiration date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) by one receipt date. PA-24-246 will now expire on September 6, 2025.
Due to the extension, the following dates will be added: Standard application due date : September 5, 2025 Scientific Merit Review: November 2025 Advisory Council: January 2026 The following sections of the FOA have been changed: Part 1.
Overview Information, Key Dates Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date September 05, 2024 * September 05, 2024 * Not Applicable November 2024 January 2025 April 2025 January 05, 2025 * January 05, 2025 * Not Applicable March 2025 May 2025 July 2025 April 05, 2025 * April 05, 2025 * Not Applicable July 2025 August 2025 December 2025 All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Revised to read (changes shown in italics ): Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date September 05, 2024 * September 05, 2024 * Not Applicable November 2024 January 2025 April 2025 January 05, 2025 * January 05, 2025 * Not Applicable March 2025 May 2025 July 2025 April 05, 2025 * April 05, 2025 * Not Applicable July 2025 August 2025 December 2025 September 05, 2025 * September 05, 2025 * Not Applicable November 2025 January 2026 April 2026 All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Please direct all inquiries to: NIH Small business Education and Entrepreneurial Development (SEED) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
Based on current listing details, eligibility includes: Small businesses located and operating in the United States with no more than 500 employees, including affiliates. Must be at least 50% individually owned and operated. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates See official notice (NIMHD encourages contacting a program official for awards exceeding standard amounts) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.